Literature DB >> 1911203

Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening.

H Joensuu1, S Toikkanen, P J Klemi.   

Abstract

Histology features, the nuclear DNA content and prognosis of 42 female breast carcinomas found in a physical examination based screening, 54 breast cancers found incidentally by medical personnel, and 274 breast cancers first suspected by the patient were compared. There was no significant difference in the distribution by primary tumour size (P = 0.08) or histological type (P = 0.87) of breast cancer between the screen-detected and 139 self-suspected cancers of women with similar mean age and living at the same time in the same city, but the screen-detected carcinomas were better differentiated (P = 0.0002), and had less mitoses (P = 0.008), less tumour necrosis (P = 0.004) and DNA aneuploidy (P = 0.01), smaller S-phase fractions (P = 0.009), less axillary metastases (P = 0.04), and had better outcome (P = 0.005) than self-suspected carcinomas. These parameters did not differ significantly between the screen-detected and incidentally found cancers, but incidental cancers had more often axillary metastases (P = 0.02). The results indicate that screen-detected breast carcinomas have favourable biological features suggesting low degree of malignant potential.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911203      PMCID: PMC1977651          DOI: 10.1038/bjc.1991.355

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.

Authors:  A L Verbeek; J H Hendriks; R Holland; M Mravunac; F Sturmans; N E Day
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

3.  Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening.

Authors:  S Shapiro; W Venet; P Strax; L Venet; R Roeser
Journal:  Natl Cancer Inst Monogr       Date:  1985-05

4.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential.

Authors:  O P Kallioniemi; A Kärkkäinen; O Auvinen; J Mattila; T Koivula; M Hakama
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

6.  Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program.

Authors:  T Hatschek; G Fagerberg; O Stål; S Sullivan; J Carstensen; O Gröntoft; B Nordenskjöld
Journal:  Cancer       Date:  1989-09-01       Impact factor: 6.860

7.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

8.  Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4',6'-diamidino-2 phenylindole dihydrochloride versus propidium iodide staining.

Authors:  R S Camplejohn; J C Macartney; R W Morris
Journal:  Cytometry       Date:  1989-07

9.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

10.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

Authors:  M Nielsen; J L Thomsen; S Primdahl; U Dyreborg; J A Andersen
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more
  3 in total

Review 1.  Is clinical breast examination an acceptable alternative to mammographic screening?

Authors:  I Mittra; M Baum; H Thornton; J Houghton
Journal:  BMJ       Date:  2000-10-28

2.  Aggressiveness of breast cancers found with and without screening.

Authors:  P J Klemi; H Joensuu; S Toikkanen; J Tuominen; O Räsänen; J Tyrkkö; I Parvinen
Journal:  BMJ       Date:  1992-02-22

3.  The epidemiological profile of women with an interval cancer in the DOM screening programme.

Authors:  C T Brekelmans; P H Peeters; J A Faber; J J Deurenberg; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.